Compare Stocks: VVOS, CTSO, LFWD, and TMDIF

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CTSO Cytosorbents	$0.40 +3.6%	$0.41	$0.35 ▼ $1.22	$25.05M	1.39	112,570 shs	71,203 shs
LFWD Lifeward	$7.34 +1.2%	$7.41	$4.14 ▼ $10.56	$20.76M	0.38	16,797 shs	2,946 shs
TMDIF Titan Medical	$0.14 -6.9%	$0.16	$0.03 ▼ $1.00	$15.82M	1.26	74,785 shs	80,049 shs
VVOS Vivos Therapeutics	$0.32 -5.5%	$0.50	$0.30 ▼ $5.12	$4.47M	6.22	1.09 million shs	1.24 million shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CTSO Cytosorbents	+1.93%	+8.67%	-10.53%	-36.88%	-57.96%
LFWD Lifeward	+1.43%	+3.79%	-15.59%	+9.01%	-12.90%
TMDIF Titan Medical	+4.23%	+10.78%	-17.18%	-47.55%	-54.17%
VVOS Vivos Therapeutics	-26.31%	-17.71%	-29.41%	-48.67%	-93.09%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CTSO Cytosorbents	$0.40 +3.6%	$0.41	$0.35 ▼ $1.22	$25.05M	1.39	112,570 shs	71,203 shs
LFWD Lifeward	$7.34 +1.2%	$7.41	$4.14 ▼ $10.56	$20.76M	0.38	16,797 shs	2,946 shs
TMDIF Titan Medical	$0.14 -6.9%	$0.16	$0.03 ▼ $1.00	$15.82M	1.26	74,785 shs	80,049 shs
VVOS Vivos Therapeutics	$0.32 -5.5%	$0.50	$0.30 ▼ $5.12	$4.47M	6.22	1.09 million shs	1.24 million shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CTSO Cytosorbents	+1.93%	+8.67%	-10.53%	-36.88%	-57.96%
LFWD Lifeward	+1.43%	+3.79%	-15.59%	+9.01%	-12.90%
TMDIF Titan Medical	+4.23%	+10.78%	-17.18%	-47.55%	-54.17%
VVOS Vivos Therapeutics	-26.31%	-17.71%	-29.41%	-48.67%	-93.09%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CTSO Cytosorbents	2.00	Hold	$5.38	1,253.90% Upside
LFWD Lifeward	2.00	Hold	$10.00	36.37% Upside
TMDIF Titan Medical	0.00	N/A	N/A	N/A
VVOS Vivos Therapeutics	2.25	Hold	$2.80	766.87% Upside

Current Analyst Ratings Breakdown

Latest VVOS, CTSO, LFWD, and TMDIF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/3/2026	LFWD Lifeward	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/27/2026	LFWD Lifeward	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/17/2026	LFWD Lifeward	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	VVOS Vivos Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/6/2026	CTSO Cytosorbents	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/4/2026	VVOS Vivos Therapeutics	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$3.00 ➝ $3.10
6/3/2026	LFWD Lifeward	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell

(Data available from 8/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CTSO Cytosorbents	$37.06M	0.67	N/A	N/A	$0.09 per share	4.41
LFWD Lifeward	$22.03M	0.94	N/A	N/A	$5.52 per share	1.33
TMDIF Titan Medical	$17.63M	0.90	$6.94 per share	0.02	$1.05 per share	0.13
VVOS Vivos Therapeutics	$19.57M	0.23	N/A	N/A	($0.16) per share	-2.02

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CTSO Cytosorbents	-$8.20M	-$0.19	N/A	13.23	N/A	-31.85%	-235.57%	-37.88%	8/6/2026 (Estimated)
LFWD Lifeward	-$19.91M	-$19.66	N/A	N/A	N/A	-123.66%	-243.14%	-97.39%	8/13/2026 (Estimated)
TMDIF Titan Medical	$6.95M	$0.05	N/A	N/A	N/A	N/A	-82.31%	-51.47%	N/A
VVOS Vivos Therapeutics	-$21.17M	-$2.14	N/A	N/A	N/A	-127.70%	-2,325.64%	-98.12%	8/18/2026 (Estimated)

Latest VVOS, CTSO, LFWD, and TMDIF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/18/2026	Q2 2026	VVOS Vivos Therapeutics	-$0.42	N/A	N/A	N/A	$5.63 million	N/A
8/13/2026	Q2 2026	LFWD Lifeward	-$1.3863	N/A	N/A	N/A	$6.53 million	N/A
8/6/2026	Q2 2026	CTSO Cytosorbents	-$0.04	N/A	N/A	N/A	$9.39 million	N/A
5/20/2026	Q1 2026	VVOS Vivos Therapeutics	-$0.45	-$0.52	-$0.07	-$0.52	$4.35 million	$5.14 million
5/15/2026	Q1 2026	LFWD Lifeward	-$1.18	-$6.70	-$5.52	-$6.70	$5.78 million	$3.92 million
5/13/2026	Q1 2026	CTSO Cytosorbents	-$0.06	-$0.08	-$0.02	-$0.08	$9.40 million	$8.86 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CTSO Cytosorbents	N/A	N/A	N/A	N/A	N/A
LFWD Lifeward	N/A	N/A	N/A	N/A	N/A
TMDIF Titan Medical	N/A	N/A	N/A	N/A	N/A
VVOS Vivos Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CTSO Cytosorbents	4.70	1.09	0.81
LFWD Lifeward	1.16	2.40	1.82
TMDIF Titan Medical	N/A	3.73	3.73
VVOS Vivos Therapeutics	N/A	0.27	0.27

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CTSO Cytosorbents	32.87%
LFWD Lifeward	26.76%
TMDIF Titan Medical	0.03%
VVOS Vivos Therapeutics	26.35%

Insider Ownership

Company	Insider Ownership
CTSO Cytosorbents	7.80%
LFWD Lifeward	1.50%
TMDIF Titan Medical	0.02%
VVOS Vivos Therapeutics	2.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CTSO Cytosorbents	220	62.84 million	57.94 million	Optionable
LFWD Lifeward	60	2.83 million	2.77 million	Optionable
TMDIF Titan Medical	50	114.04 million	4.56 million	Not Optionable
VVOS Vivos Therapeutics	160	13.90 million	13.60 million	Optionable

VVOS, CTSO, LFWD, and TMDIF Headlines

Recent News About These Companies

Vivos Therapeutics secures new US patent expanding protection for Vivos CARE technology

August 6 at 8:22 AM | msn.com

Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology

August 5 at 8:30 AM | globenewswire.com

Vivos Therapeutics (VVOS) Stock Fair Value Falls After Analyst Target Cuts

July 18, 2026 | finance.yahoo.com

Vivos Therapeutics (VVOS) Stock Sees Fair Value Moves Lower As Analysts Reset Growth Assumptions

July 3, 2026 | finance.yahoo.com

Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants

June 30, 2026 | markets.businessinsider.com

Vivos' Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants

June 30, 2026 | globenewswire.com

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

June 22, 2026 | globenewswire.com

Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering

June 11, 2026 | globenewswire.com

Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to ...

June 10, 2026 | markets.businessinsider.com

Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients

June 10, 2026 | globenewswire.com

Vivos Therapeutics, Inc. to Present at The Small Cap Showcase & WTR Insights on June 9, 2026

June 8, 2026 | quiverquant.comQ

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026

June 8, 2026 | globenewswire.com

Vivos Therapeutics Announces Debt Exchange Agreement with Streeterville Capital to Strengthen Financial Position

June 5, 2026 | quiverquant.comQ

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

June 5, 2026 | globenewswire.com

Vivos Therapeutics Inc (VVOS) Q1 2026 Earnings Call Highlights: Revenue Surges Amid Strategic Shifts

May 29, 2026 | finance.yahoo.com

Vivos Therapeutics Balances Rapid Growth With Cash Strain

May 22, 2026 | tipranks.com

Vivos Therapeutics Earnings Call: Growth Meets Cash Strain

May 21, 2026 | tipranks.com

Vivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

May 21, 2026 | finanznachrichten.de

Vivos Therapeutics, Inc. (VVOS) Q1 2026 Earnings Call Transcript

May 21, 2026 | seekingalpha.com

Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

May 20, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

VVOS, CTSO, LFWD, and TMDIF Company Descriptions

Cytosorbents NASDAQ:CTSO

$0.40 +0.01 (+3.61%)

Closing price 04:00 PM Eastern

Extended Trading

$0.35 -0.05 (-11.94%)

As of 05:16 PM Eastern

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

Lifeward NASDAQ:LFWD

$7.34 +0.09 (+1.17%)

Closing price 03:58 PM Eastern

Extended Trading

$7.50 +0.17 (+2.25%)

As of 04:37 PM Eastern

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Titan Medical NASDAQ:TMDIF

$0.14 -0.01 (-6.91%)

As of 08/5/2026

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.

Vivos Therapeutics NASDAQ:VVOS

$0.32 -0.02 (-5.46%)

Closing price 04:00 PM Eastern

Extended Trading

$0.32 +0.00 (+0.62%)

As of 06:40 PM Eastern

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest VVOS, CTSO, LFWD, and TMDIF Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest VVOS, CTSO, LFWD, and TMDIF Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

VVOS, CTSO, LFWD, and TMDIF Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

VVOS, CTSO, LFWD, and TMDIF Company Descriptions

Cytosorbents NASDAQ:CTSO

Lifeward NASDAQ:LFWD

Titan Medical NASDAQ:TMDIF

Vivos Therapeutics NASDAQ:VVOS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest VVOS, CTSO, LFWD, and TMDIF Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest VVOS, CTSO, LFWD, and TMDIF Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

VVOS, CTSO, LFWD, and TMDIF Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

VVOS, CTSO, LFWD, and TMDIF Company Descriptions

Cytosorbents NASDAQ:CTSO

Lifeward NASDAQ:LFWD

Titan Medical NASDAQ:TMDIF

Vivos Therapeutics NASDAQ:VVOS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools